Muchtaridi Muchtaridi Selected Research

mangostin

11/2022	Synthesis, Anticancer Activity, Structure-Activity Relationship, and Molecular Modeling Studies of α-Mangostin Derivatives as hERα Inhibitor.
4/2022	Alpha-mangostin as an inhibitor of GSK3β in triple-negative breast cancer.
11/2021	Nanoformulations of α-Mangostin for Cancer Drug Delivery System.
8/2021	α-Mangostin/γ-Cyclodextrin Inclusion Complex: Formation and Thermodynamic Study.
8/2021	α-Mangostin Nanoparticles Cytotoxicity and Cell Death Modalities in Breast Cancer Cell Lines.
7/2021	The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods.
5/2021	The Potential Cytotoxic Activity Enhancement of α-Mangostin in Chitosan-Kappa Carrageenan-Loaded Nanoparticle against MCF-7 Cell Line.
4/2021	Molecular dynamics simulation of Fe-NO2 At-alpha mangostin as radiopharmaceutical model for detection of fatty acid synthase in cancer.
1/2020	The purity identification and radiolabeling of α-mangostin with technetium-99m.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muchtaridi Muchtaridi Research Topics

Disease

10	Breast Neoplasms (Breast Cancer) 11/2022 - 10/2017
5	Neoplasms (Cancer) 11/2021 - 04/2021
2	Body Weight (Weight, Body) 01/2022 - 10/2019
2	COVID-19 07/2021 - 09/2020
2	Human Influenza (Influenza) 06/2021 - 02/2015
1	Neoplasm Metastasis (Metastasis) 06/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Obesity 02/2022
1	Dyslipidemias (Dyslipidemia) 02/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Hepatitis C 01/2022
1	Tuberculosis (Tuberculoses) 08/2021
1	Type 2 Diabetes Mellitus (MODY) 06/2021
1	Chronic Disease (Chronic Diseases) 06/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2021
1	Liver Diseases (Liver Disease) 06/2021
1	Ulcer 01/2021
1	Pain (Aches) 01/2021
1	Skin Ulcer 10/2020
1	Adenocarcinoma 05/2020
1	Lung Neoplasms (Lung Cancer) 05/2020
1	Infections 02/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2019
1	Amebiasis (Amoebiasis) 07/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2019
1	Colonic Neoplasms (Colon Cancer) 07/2019

Drug/Important Bio-Agent (IBA)

9	mangostinIBA 11/2022 - 01/2020
3	EnzymesIBA 01/2022 - 02/2020
3	Neuraminidase (Sialidase)IBA 06/2021 - 02/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2020
2	Estrogen ReceptorsIBA 04/2022 - 10/2017
2	AntioxidantsIBA 02/2022 - 08/2021
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2022 - 04/2021
2	Biological ProductsIBA 08/2021 - 02/2015
2	ChitosanIBA 05/2021 - 05/2021
1	human ERBB2 proteinIBA 04/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Amylases FDA Link 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	CholesterolIBA 01/2022
1	Estrogen Receptor alphaIBA 01/2022
1	GlucosidasesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 07/2021
1	Coffee FDA Link 06/2021
1	Caffeine (No Doz)FDA LinkGeneric 06/2021
1	Drug CarriersIBA 05/2021
1	Biopolymers (Biopolymer)IBA 05/2021
1	CarrageenanIBA 05/2021
1	xanthoneIBA 05/2021
1	RadiopharmaceuticalsIBA 04/2021
1	PolymersIBA 01/2021
1	SolutionsIBA 10/2020
1	FlavonoidsIBA 09/2020
1	CaspasesIBA 05/2020
1	2',4'- dihydroxy- 6'- methoxy- 3',5'- dimethylchalconeIBA 05/2020
1	Poly Adenosine Diphosphate RiboseIBA 05/2020
1	Technetium-99IBA 01/2020
1	Nanoparticle Drug Delivery SystemIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 10/2019
1	Estrogen Receptor AntagonistsIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 10/2017
1	Tamoxifen FDA LinkGeneric 10/2017

Therapy/Procedure

5	Therapeutics 06/2022 - 02/2015
2	Drug Therapy (Chemotherapy) 06/2022 - 01/2020